Low cerebrospinal fluid β-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment

被引:61
作者
Sjögren, M
Gisslén, M
Vanmechelen, E
Blennow, K
机构
[1] Sahlgrens Univ Hosp, Goteborg Univ, Inst Clin Neurosci, SE-43180 Molndal, Sweden
[2] Sahlgrens Univ Hosp, Goteborg Univ, Dept Infect Dis, SE-41685 Gothenburg, Sweden
[3] Innogenet NV, B-9052 Ghent, Belgium
[4] MRC, SE-10388 Stockholm, Sweden
关键词
Alzheimer's disease; meningitis; viral; bacterial; beta-amyloid; tau protein; biochemical markers; cerebrospinal fluid;
D O I
10.1016/S0304-3940(01)02285-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
CSF-A beta 42 may be a marker of Alzheimer's disease (AD). A decreased level of CSF-A beta 42 is consistently found in AD and has been suggested to be related to the deposition of amyloid plaques in the brain. However, low CSF-A beta 42 levels have also been found in disorders devoid of plaques, for instance Creutzfeldt-Jakob disease. To examine if the level of A beta 42 in CSF is related to inflammatory processes, we studied CSF-A beta 42 levels in eight patients with acute purulent bacterial menignitis, 10 patients with acute viral meningitis and 18 age-matched controls. In acute purulent bacterial meningitis, the CSF-A beta 42 level was markedly reduced (28% of that in controls, P < 0.0001), whereas no change was found in viral meningitis. After successful treatment of bacterial meningitis, the CSF-A beta 42 level increased (P < 0.05 compared to baseline) and did no longer differ from that in controls (ns). The decrease could not be explained by interference with high protein levels, since addition of increasing volumes of serum did not influence the CSF-A beta 42 levels. Our findings suggest that the reduction in CSF-A beta 42 found in bacterial meningitis is not a direct consequence of the inflammatory process. The cause may be disturbance of the clearance of A beta 42 from the brain. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:33 / 36
页数:4
相关论文
共 20 条
[1]   Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease:: a community based follow up study [J].
Andreasen, N ;
Vanmechelen, E ;
Van de Voorde, A ;
Davidsson, P ;
Hesse, C ;
Tarvonen, S ;
Räihä, I ;
Sourander, L ;
Winblad, B ;
Blennow, K .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03) :298-305
[2]   Cerebrospinal fluid β-amyloid(1-42) in Alzheimer disease -: Differences between early- and late-onset Alzheimer disease and stability during the course of disease [J].
Andreasen, N ;
Hesse, C ;
Davidsson, P ;
Minthon, L ;
Wallin, A ;
Winblad, B ;
Vanderstichele, H ;
Vanmechelen, E ;
Blennow, K .
ARCHIVES OF NEUROLOGY, 1999, 56 (06) :673-680
[3]   PROTEIN ANALYSES IN CEREBROSPINAL-FLUID .1. INFLUENCE OF CONCENTRATION GRADIENTS FOR PROTEINS ON CEREBROSPINAL-FLUID SERUM-ALBUMIN RATIO [J].
BLENNOW, K ;
FREDMAN, P ;
WALLIN, A ;
GOTTFRIES, CG ;
LANGSTROM, G ;
SVENNERHOLM, L .
EUROPEAN NEUROLOGY, 1993, 33 (02) :126-128
[4]   tau protein in cerebrospinal fluid - A biochemical marker for axonal degeneration in Alzheimer disease? [J].
Blennow, K ;
Wallin, A ;
Agren, H ;
Spenger, C ;
Siegfried, J ;
Vanmechelen, E .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1995, 26 (03) :231-245
[5]   High cerebrospinal fluid tau and low amyloid β42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype [J].
Galasko, D ;
Chang, L ;
Motter, R ;
Clark, CM ;
Kaye, J ;
Knopman, D ;
Thomas, R ;
Kholodenko, D ;
Schenk, D ;
Lieberburg, I ;
Miller, B ;
Green, R ;
Basherad, R ;
Kertiles, L ;
Boss, MA ;
Seubert, P .
ARCHIVES OF NEUROLOGY, 1998, 55 (07) :937-945
[6]   A beta(42) is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury [J].
Gentleman, SM ;
Greenberg, BD ;
Savage, MJ ;
Noori, M ;
Newman, SJ ;
Roberts, GW ;
Griffin, WST ;
Graham, DI .
NEUROREPORT, 1997, 8 (06) :1519-1522
[7]   Accumulation of beta-amyloid precursor [J].
Giometto, B ;
An, SF ;
Groves, M ;
Scaravilli, T ;
Geddes, JF ;
Miller, R ;
Tavolato, B ;
Beckett, AAJ ;
Scaravilli, F .
ANNALS OF NEUROLOGY, 1997, 42 (01) :34-40
[8]  
Hesse Camilla, 2000, Journal of Alzheimer's Disease, V2, P199
[9]   PROTEIN PATTERN OF CEREBROSPINAL-FLUID IN VARIOUS NEUROLOGICAL DISEASES [J].
HORNIG, CR ;
BUSSE, O ;
DORNDORF, W .
ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN, 1983, 233 (03) :253-262
[10]   VALUE OF CEREBROSPINAL-FLUID ANALYSIS IN THE DIFFERENTIAL-DIAGNOSIS OF MENINGITIS - A STUDY IN 710 PATIENTS WITH SUSPECTED CENTRAL NERVOUS-SYSTEM INFECTION [J].
LINDQUIST, L ;
LINNE, T ;
HANSSON, LO ;
KALIN, M ;
AXELSSON, G .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (03) :374-380